E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 12/15/2017 in the Prospect News Bank Loan Daily.

CenseoHealth flexes $260 million term loan to Libor plus 500 bps

By Sara Rosenberg

New York, Dec. 15 – CenseoHealth/Advance Health (Chloe Ox Parent LLC) reduced pricing on its $260 million seven-year covenant-light first-lien term loan to Libor plus 500 basis points from Libor plus 525 bps, according to a market source.

The term loan still has a 1% Libor floor, an original issue discount of 99 and 101 soft call protection for six months.

The company’s $295 million of credit facilities (B) also include a $35 million revolver.

UBS Investment Bank and Deutsche Bank Securities Inc. are the lead banks on the deal.

Recommitments were scheduled to be due at 4 p.m. ET on Friday, the source added.

Proceeds will be used to help fund the buyout of CenseoHealth LLC and Drynachan LLC (Advance Health) by New Mountain Capital for a combined $565 million in enterprise value.

CenseoHealth is a Dallas-based provider of in-home health assessments conducted by physicians. Advance Health is a Chantilly, Va.-based provider of managed care prospective health solutions.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.